Skip to main content
. Author manuscript; available in PMC: 2014 Sep 11.
Published in final edited form as: Nano Lett. 2013 Aug 9;13(9):4294–4298. doi: 10.1021/nl402054w

Figure 6.

Figure 6

Representative in-vivo fluorescence images tracking the same subjects at 15 min (a,e), 18 h (b,f), 45h (c,g) after oral gavage and the intestines after dissection at 48h (d,h). Mice (n= 3) were administered 15 mg InvaCuInSexS2-x microparticles conjugated with (e-h) wild type invasin or (a-d) the non-binding D911A variant.